Related Experiment Video
Updated: Jun 17, 2026

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management
Published on: March 28, 2025
The effect of smoking on pain-related evoked potentials
Takahiro Miyazaki1, Xiaohong Wang, Koji Inui
1Department of Integrative Physiology, National Institute for Physiological Sciences, Myodaiji-cho, Okazaki 444-8585, Japan. miyazaki@nips.ac.jp
Abstract:
The effects of human tobacco smoking and nicotine on pain-related brain activities were investigated. EEG responses evoked by a painful laser beam (laser evoked potentials; LEPs), and the plasma nicotine concentration (PNC) were measured. There were two sessions, one after smoking (Smoking session), and the other in no smoking (Control session). Subjective ratings of pain perception were also measured using the visual analog scale (VAS). Two major components, N2 and P2 of LEPs, were recorded. The amplitude of P2 was significantly smaller in the Smoking session than in the Control session. A significant negative correlation was found between PNC and the amplitude of N2 as well as P2. The results were consistent with the hypothesis that smoking and/or nicotine have an antinociceptive effect, which supports most non-human studies and some human studies. Smoking of a single tobacco cigarette did not show a subjectively perceivable extent of reduction in the intensity of evoked pain.
Related Concept Videos
Analgesia and Pain Management
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
